OCIS fellow Dr Shahid Jameel said that global data showed that getting a homologous booster was not the best strategy when India had an array of vaccines to choose from. "Covovax is the next best option if one has been vaccinated with Covishield," he said, considering that the first option of the RNA vaccine was not available in India. "India has approved nine vaccines and manufactures five but largely only uses two."

About NDTV: NDTV brings you unbiased and comprehensive coverage of news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Follow us on Social Media:
Like us on Facebook: [ Ссылка ]
Follow us on Twitter: [ Ссылка ]
Follow us on Koo: [ Ссылка ]
Follow us on Instagram: [ Ссылка ]
Join NDTV on Telegram Messenger: [ Ссылка ]

Follow us on Google News for Breaking and Latest News Updates:
NDTV: [ Ссылка ]
NDTV India (Hindi News): [ Ссылка ]

Download NDTV Mobile Apps: [ Ссылка ]

#ShahidJameel #BoosterVaccine #TheBigFight

свернуть